DK505488D0 - Middel og anvendelse af samme - Google Patents

Middel og anvendelse af samme

Info

Publication number
DK505488D0
DK505488D0 DK505488A DK505488A DK505488D0 DK 505488 D0 DK505488 D0 DK 505488D0 DK 505488 A DK505488 A DK 505488A DK 505488 A DK505488 A DK 505488A DK 505488 D0 DK505488 D0 DK 505488D0
Authority
DK
Denmark
Prior art keywords
caused
microbial
inflammation
tissue
skin
Prior art date
Application number
DK505488A
Other languages
English (en)
Inventor
Daniel Bar-Shalom
Niels Bukh
Original Assignee
Bar Shalom Daniel
Niels Bukh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK674087A external-priority patent/DK674087D0/da
Application filed by Bar Shalom Daniel, Niels Bukh filed Critical Bar Shalom Daniel
Priority to DK505488A priority Critical patent/DK505488D0/da
Publication of DK505488D0 publication Critical patent/DK505488D0/da
Priority to AU29146/89A priority patent/AU631529B2/en
Priority to DE3856442T priority patent/DE3856442T2/de
Priority to DE3853365T priority patent/DE3853365T2/de
Priority to KR1019890701561A priority patent/KR900700108A/ko
Priority to EP89901102A priority patent/EP0394333B1/en
Priority to PCT/DK1988/000216 priority patent/WO1989005645A1/en
Priority to EP94202490A priority patent/EP0640346B1/en
Priority to AT94202490T priority patent/ATE197546T1/de
Priority to JP1501022A priority patent/JPH0739347B2/ja
Priority to PCT/DK1988/000217 priority patent/WO1989005646A1/en
Priority to KR1019890701562A priority patent/KR930003117B1/ko
Priority to AU29145/89A priority patent/AU2914589A/en
Priority to EP89901101A priority patent/EP0420849A1/en
Priority to JP1501021A priority patent/JPH04500797A/ja
Priority to AT89901102T priority patent/ATE119778T1/de
Priority to DK151690A priority patent/DK151690A/da
Priority to DK151590A priority patent/DK165357C/da
Priority to DK005792A priority patent/DK169018B1/da
Priority to DK199400203A priority patent/DK174560B1/da
Priority to US08/462,277 priority patent/US5916880A/en
Priority to US08/462,278 priority patent/US5908836A/en
Priority to HK56396A priority patent/HK56396A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Polymerisation Methods In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK505488A 1987-12-21 1988-09-09 Middel og anvendelse af samme DK505488D0 (da)

Priority Applications (23)

Application Number Priority Date Filing Date Title
DK505488A DK505488D0 (da) 1987-12-21 1988-09-09 Middel og anvendelse af samme
JP1501021A JPH04500797A (ja) 1987-12-21 1988-12-21 スクラルファートの用途
AT89901102T ATE119778T1 (de) 1987-12-21 1988-12-21 Verwendung von sulfatierten zuckern.
JP1501022A JPH0739347B2 (ja) 1987-12-21 1988-12-21 硫酸化糖類の用途
AU29145/89A AU2914589A (en) 1987-12-21 1988-12-21 Use of sucralfate
DE3853365T DE3853365T2 (de) 1987-12-21 1988-12-21 Verwendung von sulfatierten zuckern.
KR1019890701561A KR900700108A (ko) 1987-12-21 1988-12-21 수크랄페이트의 용도
EP89901102A EP0394333B1 (en) 1987-12-21 1988-12-21 Uses of sulphated sugars
PCT/DK1988/000216 WO1989005645A1 (en) 1987-12-21 1988-12-21 Use of sucralfate
EP94202490A EP0640346B1 (en) 1987-12-21 1988-12-21 Uses of sulphated sugars against inflammation
AT94202490T ATE197546T1 (de) 1987-12-21 1988-12-21 Verwendung von sulfatierten zuckern gegen entzundung
AU29146/89A AU631529B2 (en) 1987-12-21 1988-12-21 Uses of sulphated sugars
PCT/DK1988/000217 WO1989005646A1 (en) 1987-12-21 1988-12-21 Uses of sulphated sugars
KR1019890701562A KR930003117B1 (ko) 1987-12-21 1988-12-21 황산화 이당류를 활성성분으로 함유하는 염증예방 또는 치료용 제약조성물
DE3856442T DE3856442T2 (de) 1987-12-21 1988-12-21 Verwendung von sulfatierten Zuckern gegen Entzundung
EP89901101A EP0420849A1 (en) 1987-12-21 1988-12-21 Use of sucralfate
DK151590A DK165357C (da) 1987-12-21 1990-06-21 Anvendelse af sulfaterede disaccharid eller et salt eller kompleks deraf til fremstilling af et laegemiddel til profylakse eller behandling af inflammation
DK151690A DK151690A (da) 1987-12-21 1990-06-21 Anvendelse af sucralfat
DK005792A DK169018B1 (da) 1987-12-21 1992-01-17 Anvendelse af sulfaterede sukkerarter
DK199400203A DK174560B1 (da) 1987-12-21 1994-02-18 Anvendelse af sulfaterede sukkerarter til fremstilling af et præparat til behandling af skæl
US08/462,277 US5916880A (en) 1987-12-21 1995-06-05 Reduction of skin wrinkling using sulphated sugars
US08/462,278 US5908836A (en) 1987-12-21 1995-06-05 Protecting skin from radiation damage using sulphated sugars
HK56396A HK56396A (en) 1987-12-21 1996-03-28 Uses of sulphated sugars

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK674087A DK674087D0 (da) 1987-12-21 1987-12-21 Saarbehandlingsmiddel
DK505488A DK505488D0 (da) 1987-12-21 1988-09-09 Middel og anvendelse af samme

Publications (1)

Publication Number Publication Date
DK505488D0 true DK505488D0 (da) 1988-09-09

Family

ID=26067713

Family Applications (4)

Application Number Title Priority Date Filing Date
DK505488A DK505488D0 (da) 1987-12-21 1988-09-09 Middel og anvendelse af samme
DK151690A DK151690A (da) 1987-12-21 1990-06-21 Anvendelse af sucralfat
DK151590A DK165357C (da) 1987-12-21 1990-06-21 Anvendelse af sulfaterede disaccharid eller et salt eller kompleks deraf til fremstilling af et laegemiddel til profylakse eller behandling af inflammation
DK005792A DK169018B1 (da) 1987-12-21 1992-01-17 Anvendelse af sulfaterede sukkerarter

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK151690A DK151690A (da) 1987-12-21 1990-06-21 Anvendelse af sucralfat
DK151590A DK165357C (da) 1987-12-21 1990-06-21 Anvendelse af sulfaterede disaccharid eller et salt eller kompleks deraf til fremstilling af et laegemiddel til profylakse eller behandling af inflammation
DK005792A DK169018B1 (da) 1987-12-21 1992-01-17 Anvendelse af sulfaterede sukkerarter

Country Status (9)

Country Link
EP (3) EP0640346B1 (da)
JP (2) JPH04500797A (da)
KR (2) KR930003117B1 (da)
AT (2) ATE197546T1 (da)
AU (2) AU2914589A (da)
DE (2) DE3856442T2 (da)
DK (4) DK505488D0 (da)
HK (1) HK56396A (da)
WO (2) WO1989005645A1 (da)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK674087D0 (da) * 1987-12-21 1987-12-21 Bar Shalom Daniel Saarbehandlingsmiddel
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
IT1230157B (it) * 1989-06-16 1991-10-14 Lisapharma Spa Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
IL95642A0 (en) * 1989-09-15 1991-06-30 Pehrom Pharmaceutical Corp Topical preparations for treatment of ulcers and other lesions
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
ATE209498T1 (de) * 1990-08-31 2001-12-15 Chugai Pharmaceutical Co Ltd Herstellung einer vorratslösung von in wasser suspendiertem sucralfat
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
DE69120933T2 (de) * 1991-04-18 1997-01-16 Baldacci Lab Spa Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
IT1251151B (it) * 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6147059A (en) * 1992-02-20 2000-11-14 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
EP0591546A4 (en) * 1992-03-28 1994-06-01 Dott Ltd Comp External preparation for curing damage to skin
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
DK86492D0 (da) * 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
AU6362594A (en) * 1993-03-10 1994-09-26 Miles Inc. Hyaluronic acid used as a cancer treatment
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
WO1994022437A2 (en) * 1993-03-29 1994-10-13 Queen's University At Kingston Method for treating amyloidosis
US5434144A (en) * 1994-03-04 1995-07-18 The Procter & Gamble Company Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
MX9604411A (es) * 1994-03-28 1997-12-31 Univ Columbia Composicion para inactivar irritantes en fluidos.
ATE213635T1 (de) * 1994-04-26 2002-03-15 Chugai Pharmaceutical Co Ltd Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung
SE9401826D0 (sv) * 1994-05-27 1994-05-27 Pharmacia Ab Anti-Helicobacter pyroli substance
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
CA2212046A1 (en) * 1995-02-02 1996-08-08 Chugai Seiyaku Kabushiki Kaisha Sucralfate preparations
WO1996024362A1 (en) * 1995-02-07 1996-08-15 Shiseido Company, Ltd. Antiinflammatory agents
US6537977B1 (en) * 1995-09-19 2003-03-25 Seikagaku Corporation Anti-inflammatory agent
JP3263598B2 (ja) * 1995-11-01 2002-03-04 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
US5837266A (en) * 1996-04-30 1998-11-17 Hydromer, Inc. Composition, barrier film, and method for preventing contact dermatitis
CH690719A5 (it) * 1996-08-19 2000-12-29 Rotta Res B V Amsterdam Swiss Procedimento per la preparazione di sali misti della glucosamina.
WO1998017282A1 (en) * 1996-10-23 1998-04-30 Vertex Pharmaceuticals Incorporated Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
GB9625193D0 (en) 1996-12-04 1997-01-22 Ml Lab Plc Treatment of highly vascular tumours
WO1999026636A1 (fr) * 1997-11-24 1999-06-03 Zhongming Zeng Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation
FI974321A0 (fi) 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
WO1999043333A1 (en) * 1998-02-27 1999-09-02 The Althexis Company Therapeutic and prophylactic uses of negatively charged substituted disaccharides
US5902800A (en) * 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders
US7906153B2 (en) 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
BR9806540C1 (pt) * 1998-06-09 2001-05-08 Akira Yoshitome Produto farmacêutico para tratamento de hemofilia e de bronquite asmática
AU2007200916B2 (en) * 1998-10-05 2009-09-17 Kabushiki Kaisha Yakult Honsha Antibacterial agents and process for producing the same
KR100698232B1 (ko) * 1998-10-05 2007-03-21 가부시키가이샤 야쿠루트 혼샤 항균제 및 그것의 제조방법
EP1139746A4 (en) * 1998-12-22 2003-09-17 Univ North Carolina CONNECTIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISEASES AND THE ADMINISTRATION OF MEDICINAL SUBSTANCES
US6964949B2 (en) 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
BRPI0101486B1 (pt) * 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7285536B2 (en) 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
US20050100566A1 (en) * 2001-12-13 2005-05-12 Dia Pharmaceutical Co., Ltd. Gel composition for external use, pad materials and pad materials to be packed in blister containers
US7879365B2 (en) 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
CA2475224C (en) 2002-02-07 2011-11-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7265097B2 (en) 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US20060234977A1 (en) * 2003-01-23 2006-10-19 Gina Wenham Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
BRPI0412675A (pt) 2003-07-17 2006-10-03 Univ Columbia composições antimicrobianas contendo combinações sinergìsticas de compostos de amÈnio quaternário e óleos essenciais e/ou constituintes
CA2576131C (en) * 2004-08-05 2012-04-24 Ivax Drug Research Institute Ltd. Polysulfated glycosides and salts thereof
US20080249165A1 (en) * 2004-08-05 2008-10-09 Ivax Drug Research Institute Ltd. Glycosides and Salts Thereof
WO2006017752A2 (en) * 2004-08-05 2006-02-16 Ivax Corporation Sulfated oligosaccharides
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
DE602005008964D1 (de) * 2005-09-16 2008-09-25 Italfar Societa A Responsabili Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
KR20080025900A (ko) * 2006-09-19 2008-03-24 (주) 서울바이오메드 글루코사민 또는 글루코사민 유도체를 포함하는 알레르기성결막염 치료용 조성물 및 이를 사용하여 알레르기성결막염을 치료하는 방법
KR101608445B1 (ko) 2006-10-12 2016-04-01 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
GB0622688D0 (en) 2006-11-14 2006-12-27 Diosamine Dev Corp Novel compounds
GB2450087A (en) * 2007-06-11 2008-12-17 Diosamine Dev Corp Use of sulphated saccharides in the treatment of inflammatory and/or auto-immune diseases
WO2010033408A1 (en) 2008-09-17 2010-03-25 Mcgrath Patrick D Antimicrobial sucralfate paste methods and compositions
US9440099B2 (en) * 2008-11-20 2016-09-13 Laboratori Derivati Organici Spa Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
FR2953522B1 (fr) * 2009-12-07 2012-03-09 Fabre Pierre Dermo Cosmetique Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2956322A1 (fr) * 2010-02-17 2011-08-19 Urgo Lab Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.
CA2790682C (en) 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
WO2012071611A1 (en) * 2010-12-01 2012-06-07 The Australian National University Histone inhibition
ITMI20110033A1 (it) * 2011-01-17 2012-07-18 Biofarmitalia Spa Composizione terapeutica mucoadesiva a base di acido ialuronico per la prevenzione e terapia di lesioni epiteliali, delle mucose del corpo umano
FR2975994B1 (fr) * 2011-05-31 2015-03-06 Fabre Pierre Dermo Cosmetique Sucroses octasulfates de calcium, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2975993B1 (fr) * 2011-05-31 2013-06-28 Fabre Pierre Dermo Cosmetique Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2991876B1 (fr) * 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2993182B1 (fr) 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
US10716802B2 (en) 2013-03-15 2020-07-21 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
KR101649201B1 (ko) * 2014-01-22 2016-08-18 대구가톨릭대학교산학협력단 오만둥이 유래 황산다당을 유효성분으로 함유하는 피부 미백 및 주름 개선용 화장료 조성물
WO2017053970A1 (en) 2015-09-24 2017-03-30 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
FR3043556B1 (fr) * 2015-11-17 2020-01-10 Urgo Recherche Innovation Et Developpement Utilisation de composes oligosaccharidiques pour activer l'angiogenese
FR3044555B1 (fr) 2015-12-07 2020-03-06 Centre National De La Recherche Scientifique - Cnrs - Film comprenant un oligosaccharide polysulfate et un polycation et son procede de fabrication
FR3060392B1 (fr) * 2016-12-19 2019-07-12 Urgo Recherche Innovation Et Developpement Utilisation de composes oligosaccharidiques pour activer l'epidermisation
IT201700047632A1 (it) * 2017-05-03 2018-11-03 Ricerfarma Srl Composizioni topiche per mantenere e ripristinare l'omeostasi idrica della pelle

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486416A (en) * 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma
FR2503563A1 (fr) * 1981-04-09 1982-10-15 Pos Lab Composition pour collyre a base de sulfate de chondroitine a
DE3131811A1 (de) * 1981-08-12 1983-04-21 Serapharm - Michael Stroetmann, 4400 Münster Heparinsalbe zur percutanen behandlung von thrombophlebitiden oder varizen
IT1189298B (it) * 1982-06-18 1988-02-04 Manetti & Roberts Italo Brit Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
JPS5978116A (ja) * 1982-10-27 1984-05-04 Chugai Pharmaceut Co Ltd スクラルフェ−ト製剤
US4640912A (en) * 1983-06-09 1987-02-03 Hausman Marvin S Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
DE3323389A1 (de) * 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
AU555747B2 (en) * 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
CA1218601A (en) * 1983-09-02 1987-03-03 Angel B. Casillan Sucralfate suspension
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK164199C (da) * 1986-05-16 1992-10-19 Chugai Pharmaceutical Co Ltd Sucralfatpraeparat til anvendelse paa oesophagus mucosa
EP0254845A3 (en) * 1986-06-10 1989-04-19 Lescarden Inc. Immune stimulation with chondroitin sulfate
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme

Also Published As

Publication number Publication date
AU2914589A (en) 1989-07-19
DK169018B1 (da) 1994-08-01
DK151690D0 (da) 1990-06-21
DK151690A (da) 1990-08-15
JPH04500798A (ja) 1992-02-13
DK5792A (da) 1992-01-17
EP0394333B1 (en) 1995-03-15
DK165357B (da) 1992-11-16
WO1989005645A1 (en) 1989-06-29
HK56396A (en) 1996-04-03
DK165357C (da) 1993-04-05
EP0640346B1 (en) 2000-11-15
JPH0739347B2 (ja) 1995-05-01
ATE119778T1 (de) 1995-04-15
AU631529B2 (en) 1992-12-03
KR900700109A (ko) 1990-08-11
DK151590A (da) 1990-08-14
DK151590D0 (da) 1990-06-21
ATE197546T1 (de) 2000-12-15
JPH04500797A (ja) 1992-02-13
EP0640346A1 (en) 1995-03-01
EP0420849A1 (en) 1991-04-10
DK5792D0 (da) 1992-01-17
DE3856442D1 (de) 2000-12-21
DE3856442T2 (de) 2001-05-10
DE3853365D1 (de) 1995-04-20
AU2914689A (en) 1989-07-19
KR900700108A (ko) 1990-08-11
DE3853365T2 (de) 1995-07-27
WO1989005646A1 (en) 1989-06-29
EP0394333A1 (en) 1990-10-31
KR930003117B1 (ko) 1993-04-19

Similar Documents

Publication Publication Date Title
DK151690D0 (da) Anvendelse af sucralfat
Holt Cryotherapy for skin cancer: results over a 5‐year period using liquid nitrogen spray cryosurgery
Bassiouny et al. Cryosurgery in cutaneous leishmaniasis
Kingman et al. Keratoacanthoma: a clinical study
Waghmare Radiation burn—from mechanism to management
Schindl et al. Low intensity laser irradiation in the treatment of recalcitrant radiation ulcers in patients with breast cancer–long‐term results of 3 cases
Chernosky et al. Squamous cell carcinoma in lesions of disseminated superficial actinic porokeratosis: a report of two cases
Ostergard et al. Outpatient therapy of preinvasive cervical neoplasia: Selection of patients with the use of colposcopy
RU94030723A (ru) Применение интерлейкина-8
Lloyd et al. Eccrine porocarcinoma: a case report and review of the literature
Rivers et al. No effect of topical tretinoin on lentigo maligna
RU2495689C2 (ru) Способ лечения подострых и хронических неспецифических цервицитов нерожавшим женщинам, включающий курс лазерного фотофореза с применением бальнеологического средства "эльтон"-гель
CA2020199A1 (en) Uses of sulphated sugars
RU93009424A (ru) Устройство для магнито-лазерной полостной терапии
Oster-Schmidt et al. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream
JP2527757B2 (ja) 皮膚の炎症を減少させる化合物およびその組成物
Higa et al. Actinic keratosis and capecitabine therapy
RU2233184C2 (ru) Способ лечения острого сальпингоофорита
Haisfield-Wolfe et al. A nursing protocol for the management of perineal-rectal skin alterations.
Caroppo et al. Treatment of peristomal granulomatosis with hydrogen peroxide 1.0% cream: Experience with two patients.
Criado et al. Longitudinal melanonychia due to voriconazole therapy during treatment of chromoblastomycosis
Maller et al. Leiomyosarcoma vulvae
Lucky Acquired bromhidrosis in an 8-year-old boy secondary to a nasal foreign body
Shierholz et al. Pyometra complicating radiation therapy of uterine malignancy
WALLACH Cryosurgery of advanced vulvar carcinoma

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment